全文获取类型
收费全文 | 6353篇 |
免费 | 623篇 |
国内免费 | 373篇 |
专业分类
电工技术 | 604篇 |
综合类 | 459篇 |
化学工业 | 1040篇 |
金属工艺 | 377篇 |
机械仪表 | 311篇 |
建筑科学 | 331篇 |
矿业工程 | 206篇 |
能源动力 | 265篇 |
轻工业 | 557篇 |
水利工程 | 197篇 |
石油天然气 | 207篇 |
武器工业 | 96篇 |
无线电 | 651篇 |
一般工业技术 | 612篇 |
冶金工业 | 449篇 |
原子能技术 | 136篇 |
自动化技术 | 851篇 |
出版年
2024年 | 27篇 |
2023年 | 103篇 |
2022年 | 269篇 |
2021年 | 290篇 |
2020年 | 210篇 |
2019年 | 185篇 |
2018年 | 199篇 |
2017年 | 186篇 |
2016年 | 209篇 |
2015年 | 257篇 |
2014年 | 340篇 |
2013年 | 459篇 |
2012年 | 498篇 |
2011年 | 502篇 |
2010年 | 443篇 |
2009年 | 473篇 |
2008年 | 413篇 |
2007年 | 404篇 |
2006年 | 379篇 |
2005年 | 253篇 |
2004年 | 216篇 |
2003年 | 163篇 |
2002年 | 158篇 |
2001年 | 114篇 |
2000年 | 104篇 |
1999年 | 52篇 |
1998年 | 89篇 |
1997年 | 48篇 |
1996年 | 39篇 |
1995年 | 37篇 |
1994年 | 14篇 |
1993年 | 18篇 |
1992年 | 18篇 |
1991年 | 21篇 |
1990年 | 18篇 |
1989年 | 24篇 |
1988年 | 16篇 |
1987年 | 9篇 |
1986年 | 8篇 |
1985年 | 8篇 |
1984年 | 4篇 |
1983年 | 5篇 |
1982年 | 9篇 |
1981年 | 11篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 8篇 |
1976年 | 10篇 |
1975年 | 3篇 |
排序方式: 共有7349条查询结果,搜索用时 13 毫秒
31.
This work presents a method based on Computer Aided Design or CAD for facilitating the synthesis of Revolute–Revolute (R–R) dyads with adjustable moving pivots. The CAD-based method presented in this work ensures that all prescribed rigid-body parameters used to synthesize the R–R dyad satisfy particular kinematic requirements of an R–R dyad. Through the application of this CAD method, five of the six general R–R dyad constraint equations are satisfied and therefore not essential for the synthesis of the R–R dyad. By reducing the number of dyad design constraints from six to one, the user can synthesize R–R links with adjustable moving pivots for multi-phase motion and path generation applications. The example included demonstrates the use of the CAD method in the synthesis of an RRSS path generator with adjustable moving pivots. 相似文献
32.
33.
JU Weaver L Thaventhiran K Noonan JM Burrin NF Taylor MR Norman JP Monson 《Canadian Metallurgical Quarterly》1994,41(5):639-648
OBJECTIVE: Growth hormone (GH) replacement therapy in hypopituitary adults is associated with sodium and water retention. The underlying mechanisms are incompletely understood and a possible contribution of altered cortisol metabolism or action has not been evaluated. We have investigated the effect of GH replacement therapy on cortisol metabolism, cortisol binding globulin and in-vitro glucocorticoid sensitivity in a group of adult hypopituitary patients. DESIGN AND PATIENTS: We studied 19 adult hypopituitary patients (18 adult onset, M:F, 6:13), who were receiving conventional hydrocortisone (16 patients), thyroxine (14 patients), triiodothyronine (1 patient), sex steroid (9 patients), human chorionic gonadotrophin (1 patient) or desmopressin (6 patients) replacement during a 6-month, double blind controlled trial of GH therapy (active:placebo, 8:11) followed by a 6-month open phase of GH (mean dose: 0.2 IU/kg/week, range 0.051-0.27) and after a 6-week washout phase following discontinuation of GH therapy. MEASUREMENTS: Twenty-four-hour urine free cortisol, cortisol metabolites (CoM), ratio 11-hydroxy/11-oxo CoM (F/E) and ratio 5 alpha/beta tetrahydrocortisol were measured at 6 months, 12 months and after the 6 week washout phase. Serum cortisol binding globulin was measured basally, at 6 months, 12 months and after washout. Glucocorticoid sensitivity was determined in lymphocyte preparations from 8 patients, during GH therapy and after washout, using an in-vitro technique dependent on dexamethasone suppression of phytohaemagglutinin-stimulated thymidine incorporation into DNA. Plasma renin activity and aldosterone were measured after 6-12 months GH therapy and after washout. RESULTS: After 6 months of GH, in patients on hydrocortisone (n = 9), there were significant decreases in CoM (mean decrement 21%, P < 0.01), F/E (mean decreased from 1.27 to 1.0, P = 0.04; reference range 0.33-1.29) and 5 alpha/5 beta tetrahydrocortisol (mean decreased from 0.67 to 0.48, P = 0.01) and a subsequent increase after washout. Patients not on hydrocortisone (n = 2) demonstrated a normal basal F/E falling by 25% on GH therapy but no change in CoM. During 12 months of GH therapy, patients on hydrocortisone (n = 7) demonstrated a further trend to decrement in CoM (P = 0.09) which reversed after washout (P = 0.04). Urine free cortisol tended to fall during GH therapy and increased significantly following washout after 12 months treatment (P < 0.02). Serum cortisol binding globulin decreased by 20% (P < 0.05) during 12 months GH treatment but remained within the reference range. In-vitro studies demonstrated a trend to reduced glucocorticoid sensitivity on GH therapy; the maximum inhibition of phytohaemagglutinin by dexamethasone tended to be less on GH therapy (P = 0.052) and was also lower than in 29 normal volunteers (P < 0.05). There were no significant changes in plasma renin but there was a small increment in aldosterone in recumbent patients (P = 0.04) during the open phase of GH therapy in the placebo arm. CONCLUSIONS: GH therapy in hypopituitary adults is associated with an apparent reduction in availability of administered hydrocortisone as measured by urine cortisol metabolites and urine free cortisol. This effect is unlikely to be clinically significant except possibly in ACTH deficient subjects on suboptimal hydrocortisone replacement. The changes in F/E suggest that GH may directly or indirectly modulate the activity of 11 beta-hydroxysteroid dehydrogenase. The apparent decrease in glucocorticoid sensitivity during GH therapy, demonstrated in vitro, merits further investigation. 相似文献
34.
35.
MR Fibi P Hermentin JU Pauly L Lauffer G Zettlmeissl 《Canadian Metallurgical Quarterly》1995,85(5):1229-1236
Single-site glycomuteins of recombinant human erythropoietin (rhuEpo) were constructed and transiently and stably expressed in BHK-21 cells. The transient expression levels varied among muteins, being highest for mutein rhuEpoGln24 followed by wild-type rhuEpo (rhuEpowt). All other glycomuteins, including rhuEpoGln38, rhuEpoGln83, rhuEpoThr126, and rhuEpoGly126, were secreted at lower levels than rhuEpowt. Muteins expressed in stable cell lines showed similar differences in expression levels. Also each mutein could be affinity-purified from culture supernatants, and was biologically active in vivo. Based on secretion rates from BHK-21 cells, the most potent erythropoietin was rhuEpoGln24. This mutein is also considered to have biologic activities that are superior to rhuEpowt. 相似文献
36.
介绍使用Python语言开发跨平台的单词助记程序原型的方法,包括安装配置Python环境、单词数据词典文件的格式、程序的主要代码和运行过程。 相似文献
37.
38.
39.
当前的故障录波器终端受制于硬件平台,对换流站控制保护二次回路暂稳态大量数据的处理能力有限,单纯依靠软件算法提高分析准确率的空间有限,目前识别准确率无法达到可靠应用的要求.只有发生故障时,运维人员才会调取相应波形进行查看,对于大量监测波形,无法依靠人工识别出电气参量的微小变化,降低了运检人员的工作效率.本文提出一种基于AI边缘计算的监测数据实时分析预警系统,在故障录波器装置端配置AI加速模块,搭建换流站控制保护多源数据模型,采用统计分析和波形分析的多维数据处理算法,对换流站控制保护二次回路数据进行实时在线计算,以及时发现控制保护二次回路隐蔽性缺陷并预警. 相似文献
40.
在我国,风电机组需提前一天提交次日24小时的申报出力信息,由于来风具有明显的不确定性和随机性特征,风电机组次日实际出力与日前申报出力会存在一定的偏差。为解决以上问题,首先采用K-means聚类法对风电机组实际出力数据进行聚类,并生成样本集;其次,基于风电不确定性样本集构建风险中性风电机组日前申报出力决策优化模型;再次,构建基于条件风险值(CVaR)的日前申报出力优化模型;最后,基于实际数据进行了算例分析。算例分析结果表明,基于CVaR的日前申报出力决策优化模型能有效减少风电机组日前申报出力与次日实际出力的偏差,且使风电机组获得风险价值更好的申报出力,从而实现申报利润的风险可控性。 相似文献